Jump to Navigation
Recent Firm News
    Burke, Harvey & Frankowski, LLC is investigating potential claims available to shareholders of BioMimetic Therapeutics, Inc. ("BMTI" or the "Company") (NASDAQ: BMTI) related to charges of fraudulent acts and false financial reporting by the Company.
    Read more

    A regulatory lawsuit filed this week should alert holders of Apple REIT investments to consider their legal options, according to attorneys at The Doss Firm, LLC and Burke Harvey & Frankowski, LLC.
    Read more 

    FINRA Charges David Lerner & Associates With Soliciting Investors to Purchase REITs Without Fully Investigating Suitability; Lerner Marketed REITs on its Website With Misleading Returns
    Read more

    Burke, Harvey & Frankowski Hits Morgan Keegan With $1.1 Million Award: The law firms of Burke, Harvey & Frankowski and Sonn & Erez recently won an arbitration against Morgan Keegan for the sale of the firm's proprietary RMK funds.
    Read More
     
    Morgan Keegan in the news, Read More.
"Guiding you through the maze of Securities Litigation"

BURKE, HARVEY & FRANKOWSKI HITS MORGAN KEEGAN WITH $1.1 Million Award

The law firms of Burke, Harvey & Frankowski and Sonn & Erez recently won an arbitration against Morgan Keegan for the sale of the firm's proprietary RMK funds. The arbitration panel ordered Morgan Keegan to pay $1.1 million to the claimants. The panel found that the brokerage firm failed to disclose the true nature of the funds and misrepresented the funds to the investors. This case is the first case in which the Securities and Exchange Commission's Wells notice was admitted into evidence. This award marks the second time in less than a week that a FINRA panel has ruled against Morgan Keegan. On Friday, February 19, an arbitration panel awarded $2.5 million to an investor in a case involving the same RMK funds. Burke, Harvey & Frankowski currently represents over 350 clients in claims against Morgan Keegan.

To read the full article, click HERE.